Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods
- PMID: 18599247
- DOI: 10.1016/j.jpba.2008.05.028
Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods
Abstract
Bisphosphonates is a class of chemical compounds finding extensive medical applications against bone disorders including osteoporosis, Pagets' disease, etc. Non-N-containing members include etidronate, clodronate and tiludronate, while N-containing bisphosphonates include active pharmaceutical compounds such as pamidronate, neridronate, olpadronate, alendronate, ibandronate, risedronate and zoledronate. The present study covers 20 years of analytical research on this group of compounds, focusing on bioanalytical and pharmaceutical QC applications. A wide range of analytical techniques is presented and critically discussed including among others liquid and gas phase separations, electrophoretic, electroanalytical, automated and enzymatic approaches.
Similar articles
-
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.Bone. 2006 May;38(5):617-27. doi: 10.1016/j.bone.2005.05.003. Epub 2005 Jul 20. Bone. 2006. PMID: 16046206
-
Bisphosphonates: mode of action and pharmacology.Pediatrics. 2007 Mar;119 Suppl 2:S150-62. doi: 10.1542/peds.2006-2023H. Pediatrics. 2007. PMID: 17332236 Review.
-
Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.Eur J Pharm Biopharm. 2010 Sep;76(1):120-6. doi: 10.1016/j.ejpb.2010.05.013. Epub 2010 Jun 8. Eur J Pharm Biopharm. 2010. PMID: 20554022
-
Review of recent applications of flow injection spectrophotometry to pharmaceutical analysis.Anal Chim Acta. 2007 Apr 4;588(1):1-9. doi: 10.1016/j.aca.2007.01.060. Epub 2007 Jan 30. Anal Chim Acta. 2007. PMID: 17386786 Review.
-
Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.Basic Clin Pharmacol Toxicol. 2009 May;104(5):384-92. doi: 10.1111/j.1742-7843.2008.00374.x. Basic Clin Pharmacol Toxicol. 2009. PMID: 19413658
Cited by
-
Fabrication of Membrane Sensitive Electrodes for the Validated Electrochemical Quantification of Anti-Osteoporotic Drug Residues in Pharmaceutical Industrial Wastewater.Molecules. 2021 Aug 22;26(16):5093. doi: 10.3390/molecules26165093. Molecules. 2021. PMID: 34443681 Free PMC article.
-
A novel micro-extraction strategy for extraction of bisphosphonates from biological fluids using zirconia nanoparticles coupled with spectrofluorimetry and high performance liquid chromatography.J Food Drug Anal. 2018 Oct;26(4):1303-1311. doi: 10.1016/j.jfda.2018.03.005. Epub 2018 Apr 5. J Food Drug Anal. 2018. PMID: 30249329 Free PMC article.
-
Differential Pulse Voltammetric Electrochemical Sensor for the Detection of Etidronic Acid in Pharmaceutical Samples by Using rGO-Ag@SiO2/Au PCB.Nanomaterials (Basel). 2020 Jul 14;10(7):1368. doi: 10.3390/nano10071368. Nanomaterials (Basel). 2020. PMID: 32674260 Free PMC article.
-
Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation.Int J Mol Sci. 2022 May 25;23(11):5944. doi: 10.3390/ijms23115944. Int J Mol Sci. 2022. PMID: 35682618 Free PMC article.
-
Development of local strontium ranelate delivery systems and long term in vitro drug release studies in osteogenic medium.Sci Rep. 2018 Nov 13;8(1):16754. doi: 10.1038/s41598-018-35197-7. Sci Rep. 2018. PMID: 30425295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical